Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.48	8.49	11.83	24.11	14.29	6.98
Cash & Cash Equivalents	6.48	8.49	11.83	24.11	14.29	6.98
Cash Growth	-28.73%	-28.24%	-50.92%	68.65%	104.67%	-53.22%
Other Current Assets	0.37	0.83	0.62	0.62	0.87	0.32
Total Current Assets	6.85	9.32	12.45	24.73	15.16	7.3
Property, Plant & Equipment	0	0.04	0.34	0.42	0.56	0.72
Other Long-Term Assets	0	0	0.02	0.03	0.02	0.02
Total Long-Term Assets	0.01	0.04	0.37	0.44	0.58	0.74
Total Assets	6.85	9.36	12.81	25.17	15.74	8.04
Accounts Payable	0.32	0.66	0.78	0.28	0.73	0.81
Current Debt	0	0.04	0.14	0.13	0.12	0.11
Other Current Liabilities	0.93	0.94	1.03	2.66	1.35	0.96
Total Current Liabilities	1.25	1.63	1.94	3.07	2.2	1.88
Long-Term Debt	0	0	0.04	0.17	0.53	0.41
Total Long-Term Liabilities	0	0	0.04	0.17	0.53	0.41
Total Liabilities	1.25	1.63	1.97	3.24	2.72	2.29
Total Debt	0	0.04	0.17	0.3	0.64	0.52
Debt Growth	-	-79.41%	-42.37%	-54.05%	23.94%	-
Retained Earnings	-141.36	-139.21	-128.38	-116.9	-103.61	-94.82
Shareholders' Equity	5.6	7.73	10.84	21.93	13.02	5.75
Net Cash / Debt	6.48	8.46	11.66	23.81	13.65	6.47
Net Cash / Debt Growth	-27.63%	-27.49%	-51.03%	74.42%	111.14%	-56.69%
Net Cash Per Share	12.72	36.52	92.34	200.43	321.41	1515.35
Working Capital	5.6	7.69	10.51	21.66	12.97	5.42
Book Value Per Share	11.01	33.39	85.82	184.61	306.46	1347.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).